Clinical Trial Update: A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial from Memorial Sloan Kettering Cancer Center is testing a comprehensive prevention program to reduce lymphedema after axillary lymph node diss…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Lymphedema

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lymphedema, Lymphedema Arm | Phase 3 | Status: RECRUITING